Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Danielle M. Brander, MD, Sallie D. Allgood, MS, David A. Rizzieri, MD, Tiffany Stewart, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD PhD

Blood (2014) 124 (21): 5658.

https://doi.org/10.1182/blood.V124.21.5658.5658

Published: 2014

Journal Articles

Next-Generation Sequencing Reveals Oncogenic Driver Mutations In Both Progressive and Non-Progressive Monoclonal B Lymphocytosis

Mark C. Lanasa, MD, PhD, Doreen te Raa, MD, Sallie D. Allgood, MS, Paula Scotland, PhD, Cassie Love, MS, Zhen Sun, MS, Arend Jan van Houte, PhD, Douwe Biesma, MD, PhD, Arnon P. Kater, MD PhD, Sandeep Dave, MD

Blood (2013) 122 (21): 1615.

https://doi.org/10.1182/blood.V122.21.1615.1615

Published: 2013

Journal Articles

Laboratory Correlates and a Phase I Clinical Trial Of Lenalidomide In Combination With Plerixafor In Patients With Previously Treated Chronic Lymphocytic Leukemia

Danielle M. Brander, MD, Sallie D. Allgood, MS, Tiffany M. Simms, BS, J. Brice Weinberg, MD, Mark Lanasa, MD, PhD

Blood (2013) 122 (21): 5301.

https://doi.org/10.1182/blood.V122.21.5301.5301

Published: 2013

Journal Articles

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

Mark C. Lanasa, MD, PhD, Martha Glenn, MD, Anthony R. Mato, MD, Sallie D. Allgood, MS, Susan Wong, Benny Amore, Gary Means, Erin Stevens, Chris Yan, Gregory Friberg, Andre Goy, MD

Blood (2013) 122 (21): 678.

https://doi.org/10.1182/blood.V122.21.678.678

Published: 2013

Journal Articles

What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.

Anna Vardi, Antonis Dagklis, Lydia Scarfò, Diane F. Jelinek, PhD, Darren J Newton, Chi Doughty, PhD, Julia Almeida, Arancha Rodriguez-Caballero, Sallie D. Allgood, MS, Mark C. Lanasa, MD, PhD, Agostino Cortelezzi, MD, Ester M Orlandi, Silvio Veronese, Marco Montillo, MD, Andy Rawstron, PhD, Tait D. Shanafelt, MD, Alberto Orfao, Kostas Stamatopoulos, Paolo Ghia

Blood (2012) 120 (21): 2883.

https://doi.org/10.1182/blood.V120.21.2883.2883

Published: 2012

Journal Articles

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Daphne R. Friedman, M.D., Mark C. Lanasa, MD, PhD, Danielle M. Brander, MD, Sallie D. Allgood, MS, Evan D. Davis, BS, Hari Miskin, Srikant Viswanadha, Swaroop Vakkalanka, J. Brice Weinberg, MD

Blood (2012) 120 (21): 3914.

https://doi.org/10.1182/blood.V120.21.3914.3914

Published: 2012

Journal Articles

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

Mark C. Lanasa, MD, PhD, Sallie D. Allgood, MS, Lynn R. Goldin, PhD, Danielle M. Brander, MD, Mary L. McMaster, MD

Blood (2012) 120 (21): 2703.

https://doi.org/10.1182/blood.V120.21.2703.2703

Published: 2012

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Danielle M. Brander, MD, Sallie D. Allgood, MS, Karen M. Bond, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD, PhD

Blood (2011) 118 (21): 2850.

https://doi.org/10.1182/blood.V118.21.2850.2850

Published: 2011

Journal Articles

Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Daphne R. Friedman, MD, Patricia H. Davis, RN, BSN, OCN, Mark C. Lanasa, MD, PhD, Joseph O. Moore, MD, Jon P. Gockerman, MD, Taylor Nelson, BS, Karen M. Bond, BS, Ning Jiang, MD, Evan D. Davis, BS, Sallie D. Allgood, MS, Youwei Chen, MD, Peter Sportelli, J. Brice Weinberg, MD

Blood (2010) 116 (21): 1842.

https://doi.org/10.1182/blood.V116.21.1842.1842

Published: 2010

Journal Articles

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Blood (2009) 114 (22): 1232.

https://doi.org/10.1182/blood.V114.22.1232.1232

Published: 2009

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L Slager, PhD, Nicola J Camp, PhD, Neil E. Kay, MD, Logan G Spector, PhD, Laura Z. Rassenti, PhD, Curtis A. Hanson, MD, Jon P Gockerman, MD, Barbara K Goodman, PhD, Sara S Strom, PhD, Timothy G Call, MD, James R Cerhan, MD, PhD, Jose Leis, MD, Gerald Marti, MD, PhD, Lynn Goldin, PhD, J. Brice Weinberg, Neil E Caporaso, MD

Blood (2009) 114 (22): 1241.

https://doi.org/10.1182/blood.V114.22.1241.1241

Published: 2009

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L. Slager, PhD, Nicola Camp, PhD, Logan Spector, PhD, Laura Rassenti, PhD, Neil E. Kay, Jon P Gockerman, MD, Alicia Volkheimer, MS, Barbara K Goodman, PhD, Sara Strom, PhD, Timothy Call, MD, James Cerhan, MD, PhD, Jose F Leis, MD, PhD, Lynn Goldin, PhD, Gerald Marti, MD, PhD, J Brice Weinberg, MD, Neil Caporaso, MD, Marc C. Levesque, MD, PhD

Blood (2008) 112 (11): 3144.

https://doi.org/10.1182/blood.V112.11.3144.3144

Published: 2008

Journal Articles

Monoclonal B Cell Lymphocytosis Exhibits Biologic Diversity Similar to Chronic Lymphocytic Leukemia.

Mark C. Lanasa, MD, PhD, Sallie D. Allgood, MS, Barbara K. Goodman, PhD, John F. Whitesides, PhD, Jon P. Gockerman, MD, Joseph O. Moore, MD, J. Brice Weinberg, MD, Marc C. Levesque, MD, PhD

Blood (2007) 110 (11): 3084.

https://doi.org/10.1182/blood.V110.11.3084.3084

Published: 2007

Journal Articles

Functional and Numerical T Cell Abnormalities in Chronic Lymphocytic Leukemia.

Mark C. Lanasa, MD, PhD, Marc C. Levesque, MD,PhD, Sallie D. Allgood, MS, Jon P. Gockerman, MD, Karen Bond, BA, J. Brice Weinberg, MD

Blood (2007) 110 (11): 3085.

https://doi.org/10.1182/blood.V110.11.3085.3085

Published: 2007

Journal Articles

Monoclonal B Cell Lymphocytosis as a Marker of Inherited Predisposition to Chronic Lymphocytic Leukemia.

Mark C. Lanasa, MD, PhD, Marc C. Levesque, MD,PhD, Jon P. Gockerman, MD, Sallie D. Allgood, MS, Joseph O. Moore, MD, John F. Whitesides, PhD, J. Brice Weinberg, MD

Blood (2007) 110 (11): 3090.

https://doi.org/10.1182/blood.V110.11.3090.3090

Published: 2007

NARROW

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Next-Generation Sequencing Reveals Oncogenic Driver Mutations In Both Progressive and Non-Progressive Monoclonal B Lymphocytosis

Laboratory Correlates and a Phase I Clinical Trial Of Lenalidomide In Combination With Plerixafor In Patients With Previously Treated Chronic Lymphocytic Leukemia

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL

Monoclonal B Cell Lymphocytosis Exhibits Biologic Diversity Similar to Chronic Lymphocytic Leukemia.

Functional and Numerical T Cell Abnormalities in Chronic Lymphocytic Leukemia.

Monoclonal B Cell Lymphocytosis as a Marker of Inherited Predisposition to Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only